Sign in to view content

Port Delivery System With Ranibizumab: Key Outcomes From the Ladder Phase 2 Trial That Supported Archway Phase 3 Study Design

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2019

Arshad M. Khanani, MD

AMD Neovascular Part II Symposium

Related

Episode 176: Journal Club with Drs. Ferhina and M. Ali Khan discussing Preoperative Anti-VEGF, RD after Intravitreal Injection, and Influence of CATT Trial Results
Jayanth Sridhar, MD
Member Podcasts
2019
Prognostic Value of Subretinal Hyperreflective Material
Russell Pokroy, MD
Updates from the Field
2017
Brolucizumab in HAWK/HARRIER: Outcomes, Efficacy, & Dosing Status – Everything You Need to Know!
David M. Brown, MD
Updates from the Field
2018

Category: AMD-Neovascular

See more